Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study.
David Jiménez, Roger D Yusen, Juan Manuel Velasco...
https://pubmed.ncbi.nlm.nih.gov/42077645/Actively Recruiting
Led by Manuel Monreal · Updated on 2026-09-21
120000
Participants Needed
305
Research Sites
52 weeks
Total Duration
Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.
CONDITIONS
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
M
Mayra Hawkins
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Manuel Monreal
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 3 years
Participants provide detailed clinical information and treatment data. Researchers track health outcomes, including blood clot recurrences, bleeding events, and survival, over time.
Regular follow-up visits as per clinical routine
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
David Jiménez, Roger D Yusen, Juan Manuel Velasco...
https://pubmed.ncbi.nlm.nih.gov/42077645/Omri Cohen, Liat Waldman Radinsky, Gili Kenet...
https://pubmed.ncbi.nlm.nih.gov/38669351/David Jiménez, Behnood Bikdeli, Andrés Quezada...
https://pubmed.ncbi.nlm.nih.gov/31358508/Miguel Martín Romero, Vladimir Salazar Rosa, Pablo Demelo Rodríguez...
https://pubmed.ncbi.nlm.nih.gov/36178134/Diego Martínez-Urbistondo, Rocío G de la Garza, Paula Villares-Fernández...
https://pubmed.ncbi.nlm.nih.gov/34626318/Giuseppe Camporese, Paolo Simioni, Pierpaolo Di Micco...
https://pubmed.ncbi.nlm.nih.gov/33038286/Laurent Bertoletti, Olga Madridano, David Jiménez...
https://pubmed.ncbi.nlm.nih.gov/38205016/Behnood Bikdeli, Fares Moustafa, José Antonio Nieto...
https://pubmed.ncbi.nlm.nih.gov/35051831/Manuela Expósito-Ruiz, Juan Ignacio Arcelus, Joseph A Caprini...
https://pubmed.ncbi.nlm.nih.gov/33248295/Olivier Espitia, Alexis F Guedon, Emma Courouve...
https://pubmed.ncbi.nlm.nih.gov/42307153/Manuel Monreal
Lead Sponsor